I have to say, well done SimonGr on this one. Great commentary...

First 3 Last

Share
Profile

Follow
CASPERBAK

289 Posts.

20

01/03/21

20:22

Post #: 51431718
Share

Originally posted by SimonGr: ↑

Christopher Cooper lost a lot of his and his family’s money and credibility in that fight. If his aim was to get back at Pratt for sacking him, he inflicted a paper cut whilst losing an arm and a leg.

The board is unanimous (and includes representative of major holders). If the Coopers vote against it, their 14.7% will most likely be outvoted by just the other top 3 (who have more than 3x Copper’s holdings) What’s more there hasn’t even been a peep out of them.

I’m a little disappointed that another party hasn’t entered the ring to bid this up a notch. Still a chance post 1H results announcement - but getting less likely by the day. So I think we just need to sit and wait for the remaining 6% (tho SP will get closer as May approaches).

As an aside, looking at the annual report shareholder tables, I just realised I’m within the top 69 shareholders for RDF ... now that really brings a smile to my face!

Expand

I have to say, well done SimonGr on this one. Great commentary and that helped me with my HOLD for a long time. I've followed this one since pre the 2012 takeover offer was rejected. Unbelievable at the time. Watched it for ages and then traded it a bit. Luckily I was at my max for that stock when the latest T/O offer came in. But geez, I have to say I've seriously considered selling out and taking it off the watch list numerous times over the years. Learnt lots with this stock.

RDF Price at posting: 89.0¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

I have to say, well done SimonGr on this one. Great commentary...

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News